Skip to main content
. 2022 Oct 10;147(5-6):486–496. doi: 10.1159/000527459

Fig. 1.

Fig. 1

BARC bleeding complications (in percent) in the whole study population, the subgroup undergoing ad hoc percutaneous coronary intervention (PCI) and the subgroup undergoing coronary angiography (CA) only. There were no significant differences between clopidogrel and ticagrelor.